These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission. Coccia PF, Strandjord SE, Warkentin PI, Cheung NK, Gordon EM, Novak LJ, Shina DC, Herzig RH. Blood; 1988 Apr; 71(4):888-93. PubMed ID: 3281725 [Abstract] [Full Text] [Related]
3. Intensive therapy followed by bone marrow transplantation for patients with acute lymphocytic leukemia in second or subsequent remission: determination of prognostic factors (a report from the University of Minnesota Bone Marrow Transplantation Team). Woods WG, Nesbit ME, Ramsay NK, Krivit W, Kim TH, Goldman A, McGlave PB, Kersey JH. Blood; 1983 Jun; 61(6):1182-9. PubMed ID: 6340756 [Abstract] [Full Text] [Related]
4. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation. Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF. Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249 [Abstract] [Full Text] [Related]
5. [Allogeneic bone marrow transplantation in acute lymphoblastic leukemia of children. Analysis of prognostic factors. GEGMO (Bone Marrow Study Group) study]. Bordigoni P, Vernant JP, Souillet G, Philippe N, Maraninchi D. Arch Fr Pediatr; 1986 Dec; 43(10):765-8. PubMed ID: 3548632 [Abstract] [Full Text] [Related]
6. Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies. Champlin R, Gale RP. Semin Hematol; 1987 Jan; 24(1):55-67. PubMed ID: 3547673 [Abstract] [Full Text] [Related]
7. Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Snyder DS, Chao NJ, Amylon MD, Taguchi J, Long GD, Negrin RS, Nademanee AP, O'Donnell MR, Schmidt GM, Stein AS. Blood; 1993 Nov 01; 82(9):2920-8. PubMed ID: 8219241 [Abstract] [Full Text] [Related]
8. Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remission. Ganem G, Kuentz M, Bernaudin F, Gharbi A, Cordonnier C, Lemerle S, Karianakis G, Vinci G, Rochant H, Lebourgeois JP. Cancer; 1989 Nov 01; 64(9):1796-804. PubMed ID: 2676139 [Abstract] [Full Text] [Related]
9. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia in first remission: a cooperative study of the Groupe d'Etude de la Greffe de Moelle Osseuse. Bordigoni P, Vernant JP, Souillet G, Gluckman E, Marininchi D, Milpied N, Fischer A, Benz Lemoine E, Jouet JP, Reiffers J. J Clin Oncol; 1989 Jun 01; 7(6):747-53. PubMed ID: 2654331 [Abstract] [Full Text] [Related]
10. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease. Moussalem M, Esperou Bourdeau H, Devergie A, Baruchel A, Ribaud P, Socie G, Parquet N, Traineau R, Hirsch I, Schaison G. Bone Marrow Transplant; 1995 Jun 01; 15(6):943-7. PubMed ID: 7581095 [Abstract] [Full Text] [Related]
18. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study. Bordigoni P, Esperou H, Souillet G, Pico J, Michel G, Lacour B, Reiffers J, Sadoun A, Rohrlich P, Jouet JP, Milpied N, Lutz P, Plouvier E, Cornu G, Vannier JP, Gandemer V, Rubie H, Gratecos N, Leverger G, Stephan JL, Boutard P, Vernant JP. Br J Haematol; 1998 Aug 08; 102(3):656-65. PubMed ID: 9722290 [Abstract] [Full Text] [Related]
19. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission. Singhal S, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Mehta J. Bone Marrow Transplant; 1996 Apr 08; 17(4):637-41. PubMed ID: 8722368 [Abstract] [Full Text] [Related]